Mechanisms of Tumor and Viral Immune Escape from Natural Killer Cell-Mediated Surveillance (Q37876089)

24 August 2017

1 reference

title

Mechanisms of tumor and viral immune escape from natural killer cell-mediated surveillance (English)

1 reference

24 August 2017

Mechanisms of Tumor and Viral Immune Escape from Natural Killer Cell-Mediated Surveillance (English)

1 reference

evasion of host immune response

2 December 2024

main subject

1 reference

based on heuristic

inferred from title

immunologic monitoring

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21576922

Elke Pogge von Strandmann

2 December 2024

author

3

object named as

Elke Pogge von Strandmann

1 reference

24 August 2017

4

Ulrike Koehl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21576922

2 December 2024

author name string

Ariane Groth

1

1 reference

24 August 2017

Stephan Klöss

2

1 reference

24 August 2017

Joachim Koch

5

1 reference

24 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21576922

2 December 2024

publication date

11 May 2011

1 reference

Journal of Innate Immunity

24 August 2017

published in

1 reference

24 August 2017

volume

3

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

344-354

1 reference

24 August 2017

1 reference

Functions of natural killer cells

21 January 2018

1 reference

Human natural killer cell development and biology

21 January 2018

1 reference

Surface NK receptors and their ligands on tumor cells

21 January 2018

1 reference

Human natural killer cell function and receptors

21 January 2018

1 reference

Influence of KIR diversity on human immunity

21 January 2018

1 reference

In search of the 'missing self': MHC molecules and NK cell recognition

21 January 2018

1 reference

Hemolysis of erythrocytes by granulysin-derived peptides but not by granulysin

21 January 2018

1 reference

A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules

21 January 2018

1 reference

KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression

21 January 2018

1 reference

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia

21 January 2018

1 reference

Estimation of the size of the alloreactive NK cell repertoire: studies in individuals homozygous for the group A KIR haplotype

21 January 2018

1 reference

MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response

21 January 2018

1 reference

The KIR gene family: life in the fast lane of evolution

21 January 2018

1 reference

Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell death

21 January 2018

1 reference

NKG2D ligands: unconventional MHC class I‐like molecules exploited by viruses and cancer

21 January 2018

1 reference

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

21 January 2018

1 reference

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

21 January 2018

1 reference

Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity

21 January 2018

1 reference

Natural Innate and Adaptive Immunity to Cancer

21 January 2018

1 reference

Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium

21 January 2018

1 reference

Oxidative stress increases MICA and MICB gene expression in the human colon carcinoma cell line (CaCo-2)

21 January 2018

1 reference

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

21 January 2018

1 reference

Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo

21 January 2018

1 reference

Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance

21 January 2018

1 reference

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells

21 January 2018

1 reference

RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.

21 January 2018

1 reference

The polarization of immune cells in the tumour environment by TGFbeta

21 January 2018

1 reference

CD4 CD25 regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

21 January 2018

1 reference

Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells

21 January 2018

1 reference

Histone deacetylases and cancer

21 January 2018

1 reference

Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate

21 January 2018

1 reference

Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells

21 January 2018

1 reference

HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer.

21 January 2018

1 reference

Host immune system gene targeting by a viral miRNA

21 January 2018

1 reference

Soluble NKG2D ligands: prevalence, release, and functional impact.

21 January 2018

1 reference

Cutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding

21 January 2018

1 reference

Soluble MICA in malignant diseases

21 January 2018

1 reference

IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA.

21 January 2018

1 reference

Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.

21 January 2018

1 reference

Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.

21 January 2018

1 reference

Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands.

21 January 2018

1 reference

Tumor-associated MICA is shed by ADAM proteases

21 January 2018

1 reference

Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma

21 January 2018

1 reference

The membrane type matrix metalloproteinase MMP14 mediates constitutive shedding of MHC class I chain-related molecule A independent of A disintegrin and metalloproteinases

21 January 2018

1 reference

Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes

21 January 2018

1 reference

Differential mechanisms of shedding of the glycosylphosphatidylinositol (GPI)-anchored NKG2D ligands

21 January 2018

1 reference

Viral modulation of NK cell immunity

21 January 2018

1 reference

Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells

21 January 2018

1 reference

Immune evasion of natural killer cells by viruses

21 January 2018

1 reference

The macromolecular peptide-loading complex in MHC class I-dependent antigen presentation

21 January 2018

1 reference

The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells

21 January 2018

1 reference

NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation

21 January 2018

1 reference

Modulation of natural killer cells by human cytomegalovirus

21 January 2018

1 reference

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

21 January 2018

1 reference

MCMV glycoprotein gp40 confers virus resistance to CD8 T cells and NK cells in vivo.

21 January 2018

1 reference

Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein

21 January 2018

1 reference

Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity

21 January 2018

1 reference

NK cell activation by dendritic cells is dependent on LFA-1-mediated induction of calcium-calmodulin kinase II: inhibition by HIV-1 Tat C-terminal domain

21 January 2018

1 reference

Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus

21 January 2018

1 reference

An integrated view of the regulation of NKG2D ligands

21 January 2018

1 reference

Viral mechanisms of immune evasion

21 January 2018

1 reference

Viral subversion of the immune system

21 January 2018

1 reference

Virus-encoded homologs of cellular interleukin-10 and their control of host immune function

21 January 2018

1 reference

A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response.

21 January 2018

1 reference

Innate immune recognition and suppression of tumors

21 January 2018

1 reference

Interleukin-2 and interleukin-15: immunotherapy for cancer.

21 January 2018

1 reference

Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs

21 January 2018

1 reference

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

Suppression of Natural Killer Cell Activity and Promotion of Tumor Metastasis by Ketamine, Thiopental, and Halothane, but Not by Propofol: Mediating Mechanisms and Prophylactic Measures

21 January 2018

1 reference

Prospects for the use of NK cells in immunotherapy of human cancer.

21 January 2018

1 reference

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

21 January 2018

1 reference

Use of natural killer cells in hematopoetic stem cell transplantation

21 January 2018

1 reference

Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation.

21 January 2018

1 reference

NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect

21 January 2018

1 reference

Good manufacturing practices production of natural killer cells for immunotherapy: a six-year single-institution experience

21 January 2018

1 reference

IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation

21 January 2018

1 reference

Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children

21 January 2018

1 reference

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

21 January 2018

1 reference

NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia

21 January 2018

1 reference

Mechanisms of immune evasion of human neuroblastoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000327014

1 reference

24 August 2017

1 reference